Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Non-Current Debt (2022 - 2024)

Historic Non-Current Debt for Universe Pharmaceuticals (UPC) over the last 1 years, with Q3 2024 value amounting to $2137.5 billion.

  • Universe Pharmaceuticals' Non-Current Debt changed N/A to $2137.5 billion in Q3 2024 from the same period last year, while for Sep 2024 it was $2137.5 billion, marking a year-over-year change of. This contributed to the annual value of $2137.5 billion for FY2024, which is N/A changed from last year.
  • Per Universe Pharmaceuticals' latest filing, its Non-Current Debt stood at $2137.5 billion for Q3 2024.
  • Over the past 5 years, Universe Pharmaceuticals' Non-Current Debt peaked at $2137.5 billion during Q3 2024, and registered a low of $2.1 million during Q1 2024.